YOU ARE A PHARMACEUTICAL COMPANY
Feeling trapped by budgets or endless bureaucratic red tape? Wish you could get that on-strategy name even in the difficult pharmaceutical world?
Quensis’revolutionary methodology and breakthrough technology allows you to benefit from in-depth understanding of the Naming competitive set to discover overlooked names and roots, and to remove the tedium of naming in a highly cluttered and regulated field.
Indeed, because we have integrated into our system trademark and dotcom database, Quensis can uniquely complete innovative statistical linguitic analysis, define viable naming strategies and explore massive quantities of names, all based on more potentially available roots to net fresh and ownable names.
In addition, we have developed screening tools specifically designed to meet the needs and regulatory constraints of the pharma industry. SIMILAR 2 is a series of screening tools designed to identify and eliminate 2+ letter conflicting drug names. This helps your company save tremendous time and money.
We’ve named 10 drugs in the past 2 years. Some for the French market, some international. Therapeutic areas in which we have worked so far include gastroenterology, antihistamine, anti-migraine, anti-hypertension, cardiology and gynecology.
Whether a drug name or extension, clinical trials naming, biologics or molecule naming or scientific innovation mention, Quensis is here to help. And we always find a viable name candidate as a true solution. Unheard of in your industry!
To find out more about our pharmaceutical industry-specific solutions, please contact us at info@quensis.com
In Europe, Asia, Africa, please call: + 33.1.55.04.86.50
In North & South America, Australasia and South Pacific: +1.212.620.5960
Discover the ISIMIG case study and watch the interview of Quensis and Bouchara-Recordati by Décideurs TV
English back-translation of the interview, click here.